The diagnosis and management of skin (dermatological) problems commonly seen in primary care is a flourishing research theme at the Centre for Academic Primary Care.
Led by Dr Matthew Ridd, we conduct applied research that addresses the needs of patients, the clinicians who look after them, and the NHS.
Working with key partners in secondary care (Centre for Evidence Based Dermatology, University of Nottingham; UK Dermatology Controlled Trials Network) and primary care (Primary Care and Population Sciences, University of Southampton), our work spans from large, flagship clinical trials through to methods work and small student projects.
Our research is mainly funded by the NIHR Health Technology Assessment Programme and NIHR School for Primary Care Research, and is done in collaboration with patient charities and organisations.
- Matthew Ridd (Lead)
- Anna Gilbertson
- Emma Le Roux
- Lyn Liddiard
- Kayla Painter
- Kirsty Roberts
- Eileen Sutton
- Doug Webb
- Sian Wells
- Zoe Wilkins
- Validating a patient reported outcome measure of eczema control (ICE Study). Bhanot A, Peters T J, Ridd M J. (October 2018-July 2019)
- Spironolactone for Adult Female Acne (SAFA): pragmatic multicentre double-blind randmoised superiority trial to investigate the clinical and cost-effectiveness of spironolactone for moderate or severe persistent acne in women. Santer M, Ridd M J et al. Funder: NIHR Health Technology Assesment. (April 2018-September 2021)
- Eczema Care Online (ECO): Supporting self-care for eczema in the community. Santer M, Thomas K T, Muller I, Ridd M, Chalmers J, Lawton S, Stuart B, Griffiths G, Sach T, Langan, Roberts A, Ahmed A, Kirk H, Yardley L, Little P, Williams H. NIHR Programme Grant (September 2017-February 2023)
- Best Emollient in Eczema (BEE): Pragmatic, primary care, multi-centre, individually randomised superiority trial of four emollients in children with eczema, with internal pilot and nested qualitative study. Ridd M, Santer M, Thomas K, MacNeill S, Heawood A, Banks J, Roberts A, Garfield K, Baxter H, Barrett T, Lane A, Williams H, Hay A. Funder: NIHR Health Technology Assessment (May 2017-December 2020)
- Action PlAns for CHildren with Eczema (APACHE): A study to develop written action plans for children with eczema and explore how best to evaluate them. Ridd M, Salisbury C, Purdy S, Metcalfe C, Heawood A, Malpass A and Waldecker A. (January 2015-December 2019)
- TEST (Trial of Eczema allergy Screening Tests): feasibility randomised controlled trial with economic scoping and nested qualitative study. Ridd M, Santer M, Boyle R, Chalmers J, Blair P, Heawood A, Selman L, Coast J, Garfield K, Marriage D, Waddell L, Muller I, Kai J. Funder: NIHR School for Primary Care Research (October 2017-November 2019)
- Barrier Enhancement for Eczema Prevention (BEEP) study. Williams H, Boyle R, Ridd M, Thornton J, Lawton S, Cork M, Simpson E, Brown S, Sach T, Montgomery A, Chalmers J, Thomas K. Funder: NIHR Health Technology Assessment (October 2013-September 2021)
- Patient and carers experience of allergy testing in eczema. Chan J, Ridd M. (June-July 2019)
- Bath additives for Treatment of CHildhood Eczema (BATHE). Santer M, Williams H, Thomas K, Ridd M, Francis N, Chorozoglo M, Roberts A, Wood W, Stanton L, Stuart B, Little P. Funder: NIHR Health Technology Assessment (March 2014-August 2017)
- Emollient prescribing formularies in England and Wales. Chan J, Boyd G, Quinn P, Ridd M. (October 2016-June 2017)
- Predictors of Onset, Persistence and Psychological Impact of childhood Eczema (POPPIE). Ridd M, Morris R, Santer M, Sullivan S, Dunnill G, Magin P, Purdy S. Funder: NIHR School for Primary Care Research (July 2012-April 2013)
- The CREAM study (ChildRen with Eczema Antibiotic Management). Francis N, Sullivan F, Butler C, Hood K, Howe R, Cohen D, Kalavala M, Davey P, Ridd M. Funder: NIHR Health Technology Assessment. (June 2012-May 2015)
- Choice of Moisturiser in Eczema Treatment (COMET) - feasibility trial. Ridd M, Hollinghurst S, Redmond N, Ball N, Shaw L, Metcalfe C, Lane A, Guy R, Purdy S. Funder: NIHR Research for Patient Benefit (July 2013-December 2015)
Back to Management of Disease